These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9873212)

  • 1. Urine volume: stone risk factor and preventive measure.
    Borghi L; Meschi T; Schianchi T; Briganti A; Guerra A; Allegri F; Novarini A
    Nephron; 1999; 81 Suppl 1():31-7. PubMed ID: 9873212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial crystalluria determination and the risk of recurrence in calcium stone formers.
    Daudon M; Hennequin C; Boujelben G; Lacour B; Jungers P
    Kidney Int; 2005 May; 67(5):1934-43. PubMed ID: 15840041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of renal stones by a high fluid intake?
    Ljunghall S; Fellström B; Johansson G
    Eur Urol; 1988; 14(5):381-5. PubMed ID: 3169081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet and renal stone formation.
    Trinchieri A
    Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kidney stone and increased water intake trial in steel workers: results from a pilot study.
    Lotan Y; Antonelli J; Jiménez IB; Gharbi H; Herring R; Beaver A; Dennis A; Von Merveldt D; Carter S; Cohen A; Poindexter J; Moe OW; Pearle MS
    Urolithiasis; 2017 Apr; 45(2):177-183. PubMed ID: 27228999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the diuretic efficacy and tolerability of therapy with Rocchetta mineral water in patients with recurrent calcium kidney stones].
    Trinchieri A; Boccafoschi C; Chisena S; De Angelis M; Seveso M
    Arch Ital Urol Androl; 1999 Apr; 71(2):121-4. PubMed ID: 10408129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper metastable limit osmolality of urine as a predictor of kidney stone formation in children.
    Porowski T; Kirejczyk JK; Mrozek P; Protas P; Kozerska A; Łabieniec Ł; Szymański K; Wasilewska A
    Urolithiasis; 2019 Apr; 47(2):155-163. PubMed ID: 29356875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in urine volume accomplished by physicians treating nephrolithiasis.
    Parks JH; Goldfischer ER; Coe FL
    J Urol; 2003 Mar; 169(3):863-6. PubMed ID: 12576800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of calcium in the prevention of kidney stones.
    Heller HJ
    J Am Coll Nutr; 1999 Oct; 18(5 Suppl):373S-378S. PubMed ID: 10511317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum nutrition for kidney stone disease.
    Heilberg IP; Goldfarb DS
    Adv Chronic Kidney Dis; 2013 Mar; 20(2):165-74. PubMed ID: 23439376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.